Despite increased serum insulin, plasma glucose levels also increased nearly 2-fold (Fig 2A), indicating that the agonist increased insulin resistance nearly 10-fold, as assessed by HOMA-IR (Fig 2C). The gene discussed is INS; the disease is Insulin resistance.